Physician profile
Jason Easterday
NPI 1831689546
$10,160.46
in general payments reported to CMS, 2019-2025
19 companies · $1,940 in 2025
The $1,940 reported for 2025 was more than what 79% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $145 · 2020: $312 · 2021: $274 · 2022: $2,054 · 2023: $2,980 · 2024: $2,456 · 2025: $1,940.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,859 · Food and Beverage: $3,269 · Education: $248.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,859.23 |
| Food and Beverage | $3,269.02 |
| Education | $247.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $4,698.09 | 2020-2025 | Ams 700, General - Erectile Dysfunction, Lithovue |
| Procept Biorobotics Corporation | $1,525.01 | 2024-2025 | Aquabeam System |
| Intuitive Surgical, INC. | $1,393.97 | 2023-2024 | Da Vinci Surgical System |
| Teleflex LLC | $859.18 | 2023 | Urolift |
| Urogen Pharma, INC. | $523.41 | 2022-2023 | Jelmyto |
| Axonics, INC. | $460.74 | 2020-2024 | Axonics, Bulkamid |
| Stryker Corporation | $165.14 | 2023 | 1788 |
| Dendreon Pharmaceuticals LLC | $144.62 | 2019 | |
| Baxter Healthcare | $101.58 | 2023 | |
| Valencia Technologies Corporation | $58.48 | 2025 | Ecoin Device Kit |
| Sumitomo Pharma America, INC. | $51.78 | 2024-2025 | Gemtesa |
| Innovation Technologies INC | $37.38 | 2024 | Irrisept |
| Astrazeneca Pharmaceuticals LP | $35.06 | 2025 | Imfinzi |
| C. R. Bard, INC. & Subsidiaries | $24.66 | 2023 | Bard Urinary Drainage Bag |
| Cardinal Health 414 LLC | $17.32 | 2024 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $17.31 | 2025 | Interstim |
| Coloplast Corp | $17.05 | 2024 | |
| Astellas Pharma US INC | $16.59 | 2023 | Myrbetriq |
| Ambu INC. | $13.09 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Easterday listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.